Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 423

1.

A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).

Kapoor R, Deek MP, McIntyre R, Raman N, Kummerlowe M, Chen I, Gaver M, Wang H, Denmeade S, Lotan T, Paller C, Markowski M, Carducci M, Eisenberger M, Beer TM, Song DY, DeWeese TL, Hearn JW, Greco S, DeVille C, Desai NB, Heath EI, Liauw S, Spratt DE, Hung AY, Antonarakis ES, Tran PT.

BMC Cancer. 2019 Jun 13;19(1):572. doi: 10.1186/s12885-019-5805-z.

2.

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson J, Cheng HH, Giri VN; PCCTC Germline Genetics Working Group.

Clin Genitourin Cancer. 2019 Apr 18. pii: S1558-7673(19)30139-9. doi: 10.1016/j.clgc.2019.04.013. [Epub ahead of print]

PMID:
31171481
3.

Phase II, Multicenter, Randomized Trial of Docetaxel plus Prednisone with or Without Cediranib in Men with Chemotherapy-Naive Metastatic Castrate-Resistant Prostate Cancer.

Heath E, Heilbrun L, Mannuel H, Liu G, Lara P, Monk JP, Flaig T, Zurita A, Mack P, Vaishampayan U, Stella P, Smith D, Bolton S, Hussain A, Al-Janadi A, Silbiger D, Usman M, Ivy SP.

Oncologist. 2019 May 31. pii: theoncologist.2019-0331. doi: 10.1634/theoncologist.2019-0331. [Epub ahead of print]

PMID:
31152080
4.

Validation challenges in liquid chromatography-tandem mass spectrometry methods for the analysis of naturally occurring compounds in foodstuffs.

Golubović J, Heath E, Heath D.

Food Chem. 2019 Oct 1;294:46-55. doi: 10.1016/j.foodchem.2019.04.069. Epub 2019 Apr 20.

PMID:
31126488
5.

EXPRESS: Multi-Analytical Study of Copper-Based Historic Pigments and their Alteration Products.

Wiggins M, Heath E, Booksh K, Alcantara-Garcia J.

Appl Spectrosc. 2019 May 24:3702819856606. doi: 10.1177/0003702819856606. [Epub ahead of print] No abstract available.

PMID:
31124370
6.

The current state of molecular testing in the treatment of patients with solid tumors, 2019.

El-Deiry WS, Goldberg RM, Lenz HJ, Shields AF, Gibney GT, Tan AR, Brown J, Eisenberg B, Heath EI, Phuphanich S, Kim E, Brenner AJ, Marshall JL.

CA Cancer J Clin. 2019 May 22. doi: 10.3322/caac.21560. [Epub ahead of print] Review.

7.

Racial differences in patterns of treatment among men diagnosed with de novo advanced prostate cancer: A SEER-Medicare investigation.

Beebe-Dimmer JL, Ruterbusch JJ, Cooney KA, Bolton A, Schwartz K, Schwartz AG, Heath E.

Cancer Med. 2019 Jun;8(6):3325-3335. doi: 10.1002/cam4.2092. Epub 2019 May 15.

8.

Prostate Cancer National Summit's Call to Action.

Heath EI, Nanus DM, Slovin S, Strand C, Higano C, Simons VH, Johnson C, Kyriakopoulos CE, Reichert ZR, Lory S, George DJ, Mucci LA, Marcus JD, Trendel JA, Bock CH.

Clin Genitourin Cancer. 2019 Jun;17(3):161-168. doi: 10.1016/j.clgc.2019.04.002. Epub 2019 Apr 16. No abstract available.

PMID:
31085057
9.

Genomic correlates of clinical outcome in advanced prostate cancer.

Abida W, Cyrta J, Heller G, Prandi D, Armenia J, Coleman I, Cieslik M, Benelli M, Robinson D, Van Allen EM, Sboner A, Fedrizzi T, Mosquera JM, Robinson BD, De Sarkar N, Kunju LP, Tomlins S, Wu YM, Nava Rodrigues D, Loda M, Gopalan A, Reuter VE, Pritchard CC, Mateo J, Bianchini D, Miranda S, Carreira S, Rescigno P, Filipenko J, Vinson J, Montgomery RB, Beltran H, Heath EI, Scher HI, Kantoff PW, Taplin ME, Schultz N, deBono JS, Demichelis F, Nelson PS, Rubin MA, Chinnaiyan AM, Sawyers CL.

Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11428-11436. doi: 10.1073/pnas.1902651116. Epub 2019 May 6.

10.

Midterm Outcomes of Arthroscopic Reduction and Internal Fixation of Anterior Cruciate Ligament Tibial Eminence Avulsion Fractures With K-Wire Fixation.

Leie M, Heath E, Shumborski S, Salmon L, Roe J, Pinczewski L.

Arthroscopy. 2019 May;35(5):1533-1544. doi: 10.1016/j.arthro.2018.11.066. Epub 2019 Apr 9.

PMID:
30979622
11.

The Epidemiology of Cancer Among Homeless Adults in Metropolitan Detroit.

Holowatyj AN, Heath EI, Pappas LM, Ruterbusch JJ, Gorski DH, Triest JA, Park HK, Beebe-Dimmer JL, Schwartz AG, Cote ML, Schwartz KL.

JNCI Cancer Spectr. 2019 Mar;3(1):pkz006. doi: 10.1093/jncics/pkz006. Epub 2019 Mar 25.

12.

Photochemical degradation of BPF, BPS and BPZ in aqueous solution: Identification of transformation products and degradation kinetics.

Kovačič A, Gys C, Kosjek T, Covaci A, Heath E.

Sci Total Environ. 2019 May 10;664:595-604. doi: 10.1016/j.scitotenv.2019.02.064. Epub 2019 Feb 5.

PMID:
30763840
13.

Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.

Carlo MI, Giri VN, Paller CJ, Abida W, Alumkal JJ, Beer TM, Beltran H, George DJ, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Ryan CJ, Schaeffer EM, Stadler WM, Taplin ME, Kauff ND, Vinson J, Antonarakis ES, Cheng HH.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.18.00060. Epub 2018 Aug 16.

14.

A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.

McHugh D, Eisenberger M, Heath EI, Bruce J, Danila DC, Rathkopf DE, Feldman J, Slovin SF, Anand B, Chu R, Lackey J, Reyno L, Antonarakis ES, Morris MJ.

Invest New Drugs. 2019 Feb 6. doi: 10.1007/s10637-019-00731-5. [Epub ahead of print]

PMID:
30725389
15.

Risk characterization of bisphenol-A in the Slovenian population starting from human biomonitoring data.

Sarigiannis DA, Tratnik JS, Mazej D, Kosjek T, Heath E, Horvat M, Anesti O, Karakitsios SP.

Environ Res. 2019 Mar;170:293-300. doi: 10.1016/j.envres.2018.12.056. Epub 2018 Dec 25.

PMID:
30605834
16.

Consolidated vs new advanced treatment methods for the removal of contaminants of emerging concern from urban wastewater.

Rizzo L, Malato S, Antakyali D, Beretsou VG, Đolić MB, Gernjak W, Heath E, Ivancev-Tumbas I, Karaolia P, Lado Ribeiro AR, Mascolo G, McArdell CS, Schaar H, Silva AMT, Fatta-Kassinos D.

Sci Total Environ. 2019 Mar 10;655:986-1008. doi: 10.1016/j.scitotenv.2018.11.265. Epub 2018 Nov 20. Review.

PMID:
30577146
17.

Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review.

Sheng S, Margarida Bernardo M, Dzinic SH, Chen K, Heath EI, Sakr WA.

Cancer Metastasis Rev. 2018 Dec;37(4):655-663. doi: 10.1007/s10555-018-9767-4. Review.

PMID:
30484007
18.

5-Year Survival of Pediatric Anterior Cruciate Ligament Reconstruction With Living Donor Hamstring Tendon Grafts.

Heath EL, Salmon LJ, Cooper R, Pappas E, Roe JP, Pinczewski LA.

Am J Sports Med. 2019 Jan;47(1):41-51. doi: 10.1177/0363546518804502. Epub 2018 Nov 26.

PMID:
30476437
19.

Down-regulation of AR splice variants through XPO1 suppression contributes to the inhibition of prostate cancer progression.

Aboukameel A, Muqbil I, Baloglu E, Senapedis W, Landesman Y, Argueta C, Kauffman M, Chang H, Kashyap T, Shacham S, Neggers JE, Daelemans D, Heath EI, Azmi AS.

Oncotarget. 2018 Oct 19;9(82):35327-35342. doi: 10.18632/oncotarget.26239. eCollection 2018 Oct 19.

20.

Monte Carlo and analytic modeling of an Elekta Infinity linac with Agility MLC: Investigating the significance of accurate model parameters for small radiation fields.

Gholampourkashi S, Cygler JE, Belec J, Vujicic M, Heath E.

J Appl Clin Med Phys. 2019 Jan;20(1):55-67. doi: 10.1002/acm2.12485. Epub 2018 Nov 8.

21.

Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in Prostate Cancer.

Heath EI, Heilbrun LK, Smith D, Schopperle WM, Ju Y, Bolton S, Ahmed Q, Sakr WA.

Anticancer Res. 2018 Nov;38(11):6361-6366. doi: 10.21873/anticanres.12994.

PMID:
30396958
22.

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.

Rodrigues DN, Rescigno P, Liu D, Yuan W, Carreira S, Lambros MB, Seed G, Mateo J, Riisnaes R, Mullane S, Margolis C, Miao D, Miranda S, Dolling D, Clarke M, Bertan C, Crespo M, Boysen G, Ferreira A, Sharp A, Figueiredo I, Keliher D, Aldubayan S, Burke KP, Sumanasuriya S, Fontes MS, Bianchini D, Zafeiriou Z, Mendes LST, Mouw K, Schweizer MT, Pritchard CC, Salipante S, Taplin ME, Beltran H, Rubin MA, Cieslik M, Robinson D, Heath E, Schultz N, Armenia J, Abida W, Scher H, Lord C, D'Andrea A, Sawyers CL, Chinnaiyan AM, Alimonti A, Nelson PS, Drake CG, Van Allen EM, de Bono JS.

J Clin Invest. 2018 Nov 1;128(11):5185. doi: 10.1172/JCI125184. Epub 2018 Nov 1. No abstract available.

23.

Continuous aperture dose calculation and optimization for volumetric modulated arc therapy.

Christiansen E, Heath E, Xu T.

Phys Med Biol. 2018 Oct 26;63(21):21NT01. doi: 10.1088/1361-6560/aae65e.

PMID:
30362464
24.
25.

Biomarkers and Bone Imaging Dynamics Associated with Clinical Outcomes of Oral Cabozantinib Therapy in Metastatic Castrate-Resistant Prostate Cancer.

Vaishampayan UN, Podgorski I, Heilbrun LK, Lawhorn-Crews JM, Dobson KC, Boerner J, Stark K, Smith DW, Heath EI, Fontana JA, Shields AF.

Clin Cancer Res. 2019 Jan 15;25(2):652-662. doi: 10.1158/1078-0432.CCR-18-1473. Epub 2018 Oct 16.

PMID:
30327304
26.

The occurrence of contaminants of emerging concern in Slovenian and Croatian wastewaters and receiving Sava river.

Česen M, Ahel M, Terzić S, Heath DJ, Heath E.

Sci Total Environ. 2019 Feb 10;650(Pt 2):2446-2453. doi: 10.1016/j.scitotenv.2018.09.238. Epub 2018 Sep 21.

PMID:
30293000
27.

Urinary bisphenol A in children, mothers and fathers from Slovenia: Overall results and determinants of exposure.

Snoj Tratnik J, Kosjek T, Heath E, Mazej D, Ćehić S, Karakitsios SP, Sarigiannis DA, Horvat M.

Environ Res. 2019 Jan;168:32-40. doi: 10.1016/j.envres.2018.09.004. Epub 2018 Sep 7.

PMID:
30253314
28.

Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosis.

Kalpage HA, Bazylianska V, Recanati MA, Fite A, Liu J, Wan J, Mantena N, Malek MH, Podgorski I, Heath EI, Vaishnav A, Edwards BF, Grossman LI, Sanderson TH, Lee I, Hüttemann M.

FASEB J. 2019 Feb;33(2):1540-1553. doi: 10.1096/fj.201801417R. Epub 2018 Sep 17.

PMID:
30222078
29.

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.

Nava Rodrigues D, Rescigno P, Liu D, Yuan W, Carreira S, Lambros MB, Seed G, Mateo J, Riisnaes R, Mullane S, Margolis C, Miao D, Miranda S, Dolling D, Clarke M, Bertan C, Crespo M, Boysen G, Ferreira A, Sharp A, Figueiredo I, Keliher D, Aldubayan S, Burke KP, Sumanasuriya S, Fontes MS, Bianchini D, Zafeiriou Z, Teixeira Mendes LS, Mouw K, Schweizer MT, Pritchard CC, Salipante S, Taplin ME, Beltran H, Rubin MA, Cieslik M, Robinson D, Heath E, Schultz N, Armenia J, Abida W, Scher H, Lord C, D'Andrea A, Sawyers CL, Chinnaiyan AM, Alimonti A, Nelson PS, Drake CG, Van Allen EM, de Bono JS.

J Clin Invest. 2018 Oct 1;128(10):4441-4453. doi: 10.1172/JCI121924. Epub 2018 Sep 4. Erratum in: J Clin Invest. 2018 Nov 1;128(11):5185.

30.

Correction to: Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW.

Adv Ther. 2018 Sep;35(9):1452. doi: 10.1007/s12325-018-0767-0.

31.

Methoxyflurane for Procedural Analgesia at 4470 m Altitude.

Wilkes M, Heath EC, Mason NP.

Wilderness Environ Med. 2018 Sep;29(3):388-391. doi: 10.1016/j.wem.2018.02.011. Epub 2018 Jul 26.

PMID:
30057014
32.

RECORDS: improved Reporting of montE CarlO RaDiation transport Studies.

Sechopoulos I, Rogers DWO, Bazalova-Carter M, Bolch WE, Heath EC, McNitt-Gray MF, Sempau J, Williamson JF.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):792-793. doi: 10.1016/j.ijrobp.2018.04.003. Epub 2018 Apr 14. No abstract available.

PMID:
29976491
33.

Seasonal and spatial variations in the occurrence, mass loadings and removal of compounds of emerging concern in the Slovene aqueous environment and environmental risk assessment.

Česen M, Heath D, Krivec M, Košmrlj J, Kosjek T, Heath E.

Environ Pollut. 2018 Nov;242(Pt A):143-154. doi: 10.1016/j.envpol.2018.06.052. Epub 2018 Jun 26.

PMID:
29966838
34.

Patterns of Bicalutamide Use in Prostate Cancer Treatment: A U.S. Real-World Analysis Using the SEER-Medicare Database.

Beebe-Dimmer JL, Ruterbusch JJ, Bylsma LC, Gillezeau C, Fryzek J, Schultz NM, Flanders SC, Barlev A, Heath E, Quek RGW.

Adv Ther. 2018 Sep;35(9):1438-1451. doi: 10.1007/s12325-018-0738-5. Epub 2018 Jun 26. Erratum in: Adv Ther. 2018 Aug 16;:.

35.

Suspect and untargeted screening of bisphenol S metabolites produced by in vitro human liver metabolism.

Gys C, Kovačič A, Huber C, Lai FY, Heath E, Covaci A.

Toxicol Lett. 2018 Oct 1;295:115-123. doi: 10.1016/j.toxlet.2018.05.034. Epub 2018 Jun 18.

PMID:
29908846
36.

Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.

Wu YM, Cieślik M, Lonigro RJ, Vats P, Reimers MA, Cao X, Ning Y, Wang L, Kunju LP, de Sarkar N, Heath EI, Chou J, Feng FY, Nelson PS, de Bono JS, Zou W, Montgomery B, Alva A; PCF/SU2C International Prostate Cancer Dream Team, Robinson DR, Chinnaiyan AM.

Cell. 2018 Jun 14;173(7):1770-1782.e14. doi: 10.1016/j.cell.2018.04.034.

37.

Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas.

Thompson JA, Motzer RJ, Molina AM, Choueiri TK, Heath EI, Redman BG, Sangha RS, Ernst DS, Pili R, Kim SK, Reyno L, Wiseman A, Trave F, Anand B, Morrison K, Doñate F, Kollmannsberger CK.

Clin Cancer Res. 2018 Sep 15;24(18):4399-4406. doi: 10.1158/1078-0432.CCR-18-0481. Epub 2018 May 30.

PMID:
29848572
38.

Development of a deformable phantom for experimental verification of 4D Monte Carlo simulations in a deforming anatomy.

Gholampourkashi S, Cygler JE, Lavigne B, Heath E.

Phys Med. 2018 Jul;51:81-90. doi: 10.1016/j.ejmp.2018.05.012.

PMID:
29776740
39.

Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors.

Von Hoff DD, Rasco DW, Heath EI, Munster PN, Schellens JHM, Isambert N, Tourneau CL, O'Neil B, Mathijssen RHJ, Lopez-Martin JA, Edenfield WJ, Martin M, LoRusso PM, Bray GL, DiMartino J, Nguyen A, Liu K, Laille E, Bendell JC.

Clin Cancer Res. 2018 Sep 1;24(17):4072-4080. doi: 10.1158/1078-0432.CCR-17-3716. Epub 2018 May 15.

PMID:
29764853
40.

Biomarkers of exposure in environment-wide association studies - Opportunities to decode the exposome using human biomonitoring data.

Steckling N, Gotti A, Bose-O'Reilly S, Chapizanis D, Costopoulou D, De Vocht F, Garí M, Grimalt JO, Heath E, Hiscock R, Jagodic M, Karakitsios SP, Kedikoglou K, Kosjek T, Leondiadis L, Maggos T, Mazej D, Polańska K, Povey A, Rovira J, Schoierer J, Schuhmacher M, Špirić Z, Stajnko A, Stierum R, Tratnik JS, Vassiliadou I, Annesi-Maesano I, Horvat M, Sarigiannis DA.

Environ Res. 2018 Jul;164:597-624. doi: 10.1016/j.envres.2018.02.041. Epub 2018 Apr 5. Review.

41.

Racial Disparities in the Molecular Landscape of Cancer.

Heath EI, Lynce F, Xiu J, Ellerbrock A, Reddy SK, Obeid E, Liu SV, Bollig-Fischer A, Separovic D, Vanderwalde A.

Anticancer Res. 2018 Apr;38(4):2235-2240.

42.

Phase I Trial of the Combination of Docetaxel, Prednisone, and Pasireotide in Metastatic Castrate-Resistant Prostate Cancer.

Thakur MK, Heilbrun L, Dobson K, Boerner J, Stark K, Li J, Smith D, Heath E, Fontana J, Vaishampayan U.

Clin Genitourin Cancer. 2018 Jun;16(3):e695-e703. doi: 10.1016/j.clgc.2018.01.019. Epub 2018 Feb 13.

43.

Local Anesthetic Systemic Toxicity Induced Cardiac Arrest After Topicalization for Transesophageal Echocardiography and Subsequent Treatment With Extracorporeal Cardiopulmonary Resuscitation.

Bacon B, Silverton N, Katz M, Heath E, Bull DA, Harig J, Tonna JE.

J Cardiothorac Vasc Anesth. 2019 Jan;33(1):162-165. doi: 10.1053/j.jvca.2018.01.044. Epub 2018 Jan 31. No abstract available.

PMID:
29525187
44.

AML refractory to primary induction with Ida-FLAG has a poor clinical outcome.

Kavanagh S, Heath E, Hurren R, Gronda M, Barghout SH, Liyanage SU, Siriwardena TP, Claudio J, Zhang T, Sukhai M, Stockley TL, Kamel-Reid S, Rostom A, Lutynski A, Khalaf D, Rydlewski A, Chan SM, Gupta V, Maze D, Sibai H, Schuh AC, Yee K, Minden MD, Schimmer AD.

Leuk Res. 2018 May;68:22-28. doi: 10.1016/j.leukres.2018.02.012. Epub 2018 Feb 20.

PMID:
29518628
45.

Introduction of a deformable x-ray CT polymer gel dosimetry system.

Maynard E, Heath E, Hilts M, Jirasek A.

Phys Med Biol. 2018 Mar 29;63(7):075014. doi: 10.1088/1361-6560/aab501.

PMID:
29515019
46.

Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin.

Herroon MK, Rajagurubandara E, Diedrich JD, Heath EI, Podgorski I.

Sci Rep. 2018 Jan 8;8(1):40. doi: 10.1038/s41598-017-17800-5.

47.

20-Year Outcomes of Anterior Cruciate Ligament Reconstruction With Hamstring Tendon Autograft: The Catastrophic Effect of Age and Posterior Tibial Slope.

Salmon LJ, Heath E, Akrawi H, Roe JP, Linklater J, Pinczewski LA.

Am J Sports Med. 2018 Mar;46(3):531-543. doi: 10.1177/0363546517741497. Epub 2017 Dec 15.

PMID:
29244525
48.

Partnering around cancer clinical trials (PACCT): study protocol for a randomized trial of a patient and physician communication intervention to increase minority accrual to prostate cancer clinical trials.

Eggly S, Hamel LM, Heath E, Manning MA, Albrecht TL, Barton E, Wojda M, Foster T, Carducci M, Lansey D, Wang T, Abdallah R, Abrahamian N, Kim S, Senft N, Penner LA.

BMC Cancer. 2017 Dec 2;17(1):807. doi: 10.1186/s12885-017-3804-5.

49.

RECORDS: improved Reporting of montE CarlO RaDiation transport Studies: Report of the AAPM Research Committee Task Group 268.

Sechopoulos I, Rogers DWO, Bazalova-Carter M, Bolch WE, Heath EC, McNitt-Gray MF, Sempau J, Williamson JF.

Med Phys. 2018 Jan;45(1):e1-e5. doi: 10.1002/mp.12702. Epub 2017 Dec 16.

PMID:
29178605
50.

Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial.

Paller CJ, Zhou XC, Heath EI, Taplin ME, Mayer T, Stein MN, Bubley GJ, Pili R, Hudson T, Kakarla R, Abbas MM, Anders NM, Dowling D, King S, Bruns AB, Wagner WD, Drake CG, Antonarakis ES, Eisenberger MA, Denmeade SR, Rudek MA, Rosner GL, Carducci MA.

Clin Cancer Res. 2018 Jan 15;24(2):306-315. doi: 10.1158/1078-0432.CCR-17-1100. Epub 2017 Nov 7.

Supplemental Content

Support Center